SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-004802
Filing Date
2017-06-14
Accepted
2017-06-14 16:16:20
Documents
52
Period of Report
2017-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmx-20170430x10q.htm 10-Q 1429664
2 EX-10.1 bpmx-20170430ex101743392.htm EX-10.1 58376
3 EX-31.1 bpmx-20170430ex311c9c4ce.htm EX-31.1 19478
4 EX-31.2 bpmx-20170430ex31286231d.htm EX-31.2 19485
5 EX-32.1 bpmx-20170430ex321f5984f.htm EX-32.1 11485
  Complete submission text file 0001558370-17-004802.txt   4843008

Data Files

Seq Description Document Type Size
6 EX-101.INS bpmx-20170430.xml EX-101.INS 848511
7 EX-101.SCH bpmx-20170430.xsd EX-101.SCH 33046
8 EX-101.CAL bpmx-20170430_cal.xml EX-101.CAL 33572
9 EX-101.DEF bpmx-20170430_def.xml EX-101.DEF 136346
10 EX-101.LAB bpmx-20170430_lab.xml EX-101.LAB 303457
11 EX-101.PRE bpmx-20170430_pre.xml EX-101.PRE 258228
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 17911316
SIC: 2834 Pharmaceutical Preparations